Stay updated on IpilimumabNivolumabLeptoMetClinicalTrial
Sign up to get notified when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.

Latest updates to the IpilimumabNivolumabLeptoMetClinicalTrial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe label 'Last Update Posted (Estimated)' was replaced with 'Last Update Posted' for the study record's update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a dedicated Locations section detailing Massachusetts-based study sites (e.g., Boston; Massachusetts General Hospital). Removed the Massachusetts Locations entry and the HHS Vulnerability Disclosure from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

- Check75 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed, replacing the previous description, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdministrative metadata updates were added, including new timestamps such as Last Update Posted (Estimated) and dates like 2025-11-14 and 2025-10-30, with no changes to trial design, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to IpilimumabNivolumabLeptoMetClinicalTrial
Enter your email address, and we'll notify you when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.